• Robert Houlden

    Formulytica Pty. Ltd., Australia

    Title: Taking your active from the lab to scale-up formulation development of a topical delivery system

  • Jan Tavernier

    Ghent University, Belgium

    Title: Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

  • Angelita Rebollo

    Sorbonne University, France

    Title: Precilinal validation of a cell penetratin and interfering peptide

  • Vladimir P Torchilin

    Northeastern University, USA

    Title: Novel developments in lipid-based multifunctional combination nanopreparations for multidrug resistant cancer

  • Kazem Alemzadeh

    University of Bristol, UK

    Title: Prototyping and evaluating a novel humanoid chewing robot for drug delivery using a medicated chewing gum

  • Ann Mari Holsater

    University of Tromso, Norway

    Title: Docetaxel-liposomes prepared by the dual centrifugation method: Effect of propylene glycol and lipid charge on liposomal characteristics

  • Georgina Kate Such

    University of Melbourne, Australia

    Title: The use of self-immolative polymers to control cellular delivery

  • Nikolay E. Polyakov

    Voevodsky Institute of Chemical Kinetics and Combustion, Russia

    Title: Physicochemical and biophysical study of mechanisms the drugs bioavailability enhancement with new multifunctional delivery systems

  • Rina Aharoni

    The Weizmann Institute of Science, Israel

    Title: The story of Glatiramer acetate (Copaxone) in the treatment of multiple sclerosis and its new applications

  • Mino R Caira

    University of Cape Town, South Africa

    Title: Synthesis and physicochemical analysis of multi-component phases in drug development

  • Rafael Vazquez-Duhalt

    Universidad Nacional Autonoma de Mexico, Mexico

    Title: Multifunctionalized and targeted biocatalytic nanoreactor for combinatory treatment of ER+ breast cancer

  • M Teresa Carvajal

    Purdue University, USA

    Title: If a picture is worth 1,000 words, what words are they? A pictorial best-worst scaling set of experiments for formulations of dry powder for inhalation

  • Tatyana Viktorovna Leshina

    Voevodsky Institute of Chemichal Kinetics and Combustion, Novosibirsk, Russia

    Title: New approach to study difference in NSAIDs enantiomer activity, including chiral inversion

  • Marianne Parent

    Universite de Lorraine, France

    Title: Nano- versus Micro-particles for S-nitrosoglutathione formulation

  • Esmaiel Jabbari

    University of South Carolina, USA

    Title: Nano drug delivery in regenerative medicine and cancer therapy

  • Sergey V Suchkov

    Sechenov University, Russia

    Title: Catalytic antibodies (Ab-Proteases) as unique biomarkers and targets to monitor and to manage chronic disorders and to serve tools for translational applications of the next-step generation

  • Ylenia Zambito

    University of Pisa, Italy

    Title: Influence of mucoadhesivity on the bioavailability of nanoparticulate drug delivery systems

  • Jingxin Mo

    Guilin Medical University, China

    Title: Calixarene Nanovesicles for Drug Delivery

  • Mayssa Abdel Hady

    National Research Center, Egypt

    Title: Achieving Lower Intraocular Pressure using Phospholipid free, release modulated lipid carriers

  • Gillian Hutcheon

    Liverpool John Moores University, UK

    Title: Nanoparticle delivery of natural products for the treatment of lung cancer

  • Farzin Roohvand

    Pasteur Institute of Iran, Iran

    Title: Role of the optimal dynamic state and stabilized catalytic complex for rational design of pharmaceutical enzymes: A mutant streptokinase (Asn228Lys/Phe287Lys) with enhanced, fibrin-dependent activity - Computational assessments and experimental validations

  • Juliette Vergnaud-Gauduchon

    Universite Paris-Sud, Paris

    Title: Liposomes as valuable drug delivery systems for siRNA and Hsp90 inhibitors to target triple negative breast tumors

  • Ulo Langel

    Stockholm University, Sweden

    Title: Cell-penetrating peptides and delivery of oligonucleotides

  • El Hassane Larhrib

    University of Huddersfield, UK

    Title: Compression and compaction of pharmaceutical powders

  • Eliana Silva De Moraes

    The Brazilian Regulatory Affairs Society – ABPVS in Europe, Brazil

    Title: Global legal tools for pharmacovigillance and risk control

  • Xincheng Hou

    ShanghaiTech University, China

    Title: High throughput evaluation of the payload delivery efficiency for immunoconjugates

  • Razan Ghattas Mhanna

    Lebanese International University, Lebanon

    Title: Pharmacovigilance: Aims, challenges and perspectives

  • Robert Walter Makuch

    Yale University, USA

    Title: To be announced..

  • Maria Carmen Agnello

    University of Bologna, Italy

    Title: Vaccines in the Italian healthcare system: Regulation and measures to support and prevent

  • Paritosh Pande

    IMA Life North America and University of Connecticut, USA

    Title: Influence of formulation and freeze drying process variations on protein stability

  • Robert P Bianchi

    Prescription Drug Research Center, USA

    Title: Government and industry response to the US opioid epidemic

  • Manuela Calin

    “N. Simionescu” of Romanian Academy, Romania

    Title: P-selectin targeted nanocarriers are efficient drug delivery systems to activated endothelium

  • Rui Tamura

    Kyoto University, Japan

    Title: Facile preparation and characterization of robust metal-free nitroxide-based magnetic mixed micelles as MRI-visible drug delivery carrier

  • Alice Chuah Lay Hong

    Monash University, Malaysia

    Title: Radiolabeled niosomes as potential passive targeting nanocarriers

  • Fabien Gosselet

    Artois University, France

    Title: Blood-brain barrier physiology in Alzheimer’s disease: LXR signaling pathway and ABC transporters as therapeutical targets

  • Elinaz Farokhi

    San Diego State University, USA

    Title: Engineering novel selectivity into metalloantibodies germline-encoded precursor to the murine anti-S1P metalloantibody in E.coli and baculovirus-insect cell system

  • Enkelejda Goci

    Aldent University, Albania

    Title: In vitro model of diclofenac sodium gel delivery through pig skin

  • Kira Astakhova

    Technical University of Denmark, Denmark

    Title: Lipid and carbohydrate based delivery vesicles for gene therapeutics: Approaching difficult diseases

  • Justine Fraser

    University of Strathclyde, UK

    Title: Release and activity of the broad spectrum antibiotic Rifampicin from biodegradable polymer PLGA

  • Bartolome Ribas Ozonas

    Royal National Academy of Pharmacy, Spain

    Title: Caloric restriction and longevity

  • Guillaume Sandoz

    Université Cote d’Azur, France

    Title: Frameshift mutation-induced alternative translation initiation as a mechanism for migraine induction invovling two-pore-domain potassium channels

  • Aditya Tatavarti

    Merck Research Laboratories, USA

    Title: Designing ADME formulations with matching exposures to amorphous solid dosage forms

  • Marlene Lucio

    University of Minho, Portugal

    Title: Pharmaceutical applications of graphene-based nanomaterials in cancer theranostics

  • Jaunius Urbonavicius

    Vilnius Gediminas Technical Universitry, Lithuania

    Title: Discovery of novel bacterial genes encoding the enzymes acting on modified uracil/uridine derivatives and their use for gene therapy in cancer treatment

  • Chie Watanabe

    Josai University, Japan

    Title: Systemic liver-targeting delivery of a novel DNA/RNA heteroduplex oligonucleotide via an enteral route

  • Gulnihal Ozcan

    Koc University, Turkey

    Title: The nuclear membrane as a barrier to the action of anthracycline chemotherapeutics

  • Mohamed Ben-Eltriki

    University of British Columbia, Canada

    Title: Preclinical evaluation of vitamin D and ginseng metabolites in combination for prostate cancer therapy: Pharmacokinetic and Pharmacodynamic based interactions

  • Paul A Millner

    University of Leeds, UK

    Title: Nano-enabled delivery of drugs and imaging agents to colorectal cancer cells in vitro and in vivo

  • Bertrand Toussaint

    Université Grenoble Alpes, France

    Title: Pseudomonas aeruginosa type 3 secretion system mediated antigen delivery for cancer immunotherapy

  • Maria van Dongen

    Johnson & Johnson, Belgium

    Title: Antibody-guided discovery of potent small-molecule fusion inhibitors of influenza virus

  • Nathalie Janel

    Universite Paris Diderot, France

    Title: Targeting liver function to circumvent neuronal and cardiac dysfunctions linked to hyperhomocysteinemia

  • Shunichiro Taniguchi

    Shinshu University, Japan

    Title: In situ delivery and production system of anti-cancer molecules with gene-engineered bifidobacterium

  • Nokyoung Park

    Myongji University, Korea

    Title: A RNA producing DNA hydrogel as a platform for a high performance RNA interference system

  • Haissam Abou Saleh

    Qatar University, Qatar

    Title: A nanomedicine approach in the treatment of arterial hypertension

  • Benfang Helen Ruan

    Zhejiang University of Technology, China

    Title: Detection of “Hidden” drug resistance by the EZMTT assay

  • Azeez Yusuf

    Technical University Dublin, Ireland

    Title: Encapsulation of silver nanoparticle in DPPC based liposome suppresses ROS, induced inflammation and enhance nanoparticle cytotoxicity

  • Agris Auce

    Rigas Stradins University, Latvia

    Title: Freshwater Sapropel as raw material in medicine and pharmaceutical production

  • Satoshi Nakata

    Hiroshima University, Japan

    Title: Self-propelled objects with high autonomy for transportation

  • Gulcin Arslan Azizoglu

    Ege University, Turkey

    Title: Wound healing mats made of layer by layer coated nanoparticles and electrospun

  • Vladimir A. D’yakonov

    Institute of Petrochemistry and Catalysis of Russian Academy of Sciences, Russia

    Title: Original synthesis of natural acetogenins, fattyacids andlembehynes as a potential drugs for treatment of cancer and neurodegenerative diseases

  • Fang Wu

    Shanghai Jiao Tong University, China

    Title: New indications for FDA-approved drugs: Selective inhibition of the growth of helicobacter pylori by covalent allosteric regulation of urease

  • Jing Yu

    Shanghai Jiao Tong University, China

    Title: Development of novel leads for triple-negative breast cancer immunotherapy

  • Jose Eduardo Cuellar

    Universidad Nacional de Colombia, Universidad Nacional de Colombia

    Title: Development of substances with biological and pharmacological activity based on structural nucleus hybrids from phytochemical compounds like secondary metabolites